(Q43196381)

English

The best-laid plans

scientific article published on 26 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

0 references

The best-laid plans (English)

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

author name string

Raymond C Harris

1

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 December 2012

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

304

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

8

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

F1086-7

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625842

25 May 2018

Bardoxolone methyl and kidney function in CKD with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625842

25 May 2018

New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625842

25 May 2018

Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625842

25 May 2018

Oxidative stress and diabetic complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625842

25 May 2018

Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625842

25 May 2018

Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625842

25 May 2018

Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3625842

15 August 2018

Identifiers

10.1152/AJPRENAL.00693.2012

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43196381&oldid=1983607981"